Drug Search Results
More Filters [+]

Guaifenesin

Alternative Names: guaifenesin, mucinex, resil, mucosa, obredon, hycofenix, xtrelus, flowtuss
Latest Update: 2024-10-25
Latest Update Note: News Article

Product Description

Guaifenesin is used to help clear mucus or phlegm (pronounced flem) from the chest when you have congestion from a cold or flu. It works by thinning the mucus or phlegm in the lungs.  (Sourced from: https://www.mayoclinic.org/drugs-supplements/guaifenesin-oral-route/side-effects/drg-20068720?p=1)

Mechanisms of Action: Blood Vessel Constrictor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Rectal

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Substance Abuse Unspecified | Common Cold

Known Adverse Events: Dizziness | Headache | Lethargy | Constipation

Company: Reckitt Benckiser
Company Location: SLOUGH X0 SL1 3UH
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Guaifenesin

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Hypospadias

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2017-000361-78

P2

Active, not recruiting

Hypospadias

2022-01-06

Recent News Events